AMLX Stock Analysis: Buy, Sell, or Hold?
AMLX - Amylyx Pharmaceuticals, Inc. Common Stock
$14.29
-0.56 (-3.77%)
▼
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 03, 2026
29d
Get Alerted When AMLX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: AMLX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: AMLX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: AMLX is currently trading at $14.29, which is considered slightly high relative to its 30-day fair value range of $11.73 to $15.11.
Technical Outlook: Technically, AMLX is in a strong uptrend. Immediate support is located at $13.45, while resistance sits at $17.49. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: AMLX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $20.22 (+41.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AMLX is in a strong uptrend. Immediate support is located at $13.45, while resistance sits at $17.49. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: AMLX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $20.22 (+41.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$11.73 -
$15.11
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
73.7%
Protect Your Profits
Holding AMLX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.8%)
- BULLISH: Trading 41.5% below Wall St target ($20.22)
- CAUTION: Recommendation downgraded due to -9.3% 5-day decline
Fair Price Analysis
30-Day Fair Range
$11.73 -
$15.11
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$13.45
Resistance Level
$17.49
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-11.44
Wall Street Target
$20.22
(+41.5%)
Revenue Growth (YoY)
-99.6%
Last updated: February 01, 2026 7:31 AM ET
Data refreshes hourly during market hours. Next update: 8:31 AM
Data refreshes hourly during market hours. Next update: 8:31 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AMLX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Camille L Bedrosian
SELL
12039 shares
2025-09-30
Gina Mazzariello
SELL
8828 shares
2025-09-30
James M Frates
SELL
10558 shares
2025-09-30
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$179 | 62 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$158 | 56 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$84 | 57 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 55 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$21 | 57 HOLD |
Advanced AMLX Option Strategies
Professional options setups generated by AI based on today's AMLX price and gamma walls.
